anti diabetic medicine

Mounjaro 10 mg Injection contains tirzepatide 10 mg, a prescription medicine that acts as a dual GIP and GLP-1 receptor agonist. It is used for the management of type 2 diabetes and, where approved, for chronic weight management. 🇬🇧 UK Mounjaro 10 mg injection UK tirzepatide 10 mg injection UK Mounjaro 10 mg UK tirzepatide prefilled pen UK tirzepatide medication UK tirzepatide for type 2 diabetes UK tirzepatide weight management UK GIP GLP-1 receptor agonist UK 🇺🇸 USA Mounjaro 10 mg injection USA tirzepatide 10 mg injection USA Mounjaro 10 mg USA tirzepatide prefilled pen USA tirzepatide medication USA tirzepatide for type 2 diabetes USA tirzepatide weight management USA GIP GLP-1 receptor agonist USA 🇨🇦 Canada Mounjaro 10 mg injection Canada tirzepatide 10 mg injection Canada Mounjaro 10 mg Canada tirzepatide prefilled pen Canada tirzepatide medication Canada tirzepatide for type 2 diabetes Canada tirzepatide weight management Canada GIP GLP-1 receptor agonist Canada 🇮🇳 India Mounjaro 10 mg injection India tirzepatide 10 mg injection India Mounjaro 10 mg India tirzepatide prefilled pen India tirzepatide medication India tirzepatide for type 2 diabetes India tirzepatide weight management India GIP GLP-1 receptor agonist India 🇦🇺 Australia Mounjaro 10 mg injection Australia tirzepatide 10 mg injection Australia Mounjaro 10 mg Australia tirzepatide prefilled pen Australia tirzepatide medication Australia tirzepatide for type 2 diabetes Australia tirzepatide weight management Australia GIP GLP-1 receptor agonist Australia 🇰🇷 South Korea Mounjaro 10 mg injection South Korea tirzepatide 10 mg injection South Korea Mounjaro 10 mg South Korea tirzepatide prefilled pen South Korea tirzepatide medication South Korea tirzepatide for type 2 diabetes South Korea tirzepatide weight management South Korea GIP GLP-1 receptor agonist South Korea 🇸🇬 Singapore Mounjaro 10 mg injection Singapore tirzepatide 10 mg injection Singapore Mounjaro 10 mg Singapore tirzepatide prefilled pen Singapore tirzepatide medication Singapore tirzepatide for type 2 diabetes Singapore tirzepatide weight management Singapore GIP GLP-1 receptor agonist Singapore

Rybelsus 14 mg contains semaglutide, an oral GLP-1 receptor agonist used to help improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise when prescribed. Semaglutide works by helping the body release insulin when blood glucose levels are elevated, reducing glucagon secretion, and slowing gastric emptying. These actions can help improve glycemic control and may also reduce appetite and food intake. UK UK Rybelsus 14 mg semaglutide 14 mg tablets Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription diabetes medicine USA Rybelsus 14 mg semaglutide 14 mg Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription semaglutide 🇮🇳 India Rybelsus 14 mg semaglutide 14 mg tablets Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects diabetes treatment tablets 🇦🇺 Australia Rybelsus 14 mg semaglutide 14 mg Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription semaglutide 🇰🇷 South Korea Rybelsus 14 mg semaglutide 14 mg Rybelsus tablets oral semaglutide semaglutide diabetes treatment Rybelsus uses Rybelsus side effects prescription semaglutide 🇨🇦 Canada Rybelsus 14 mg semaglutide 14 mg Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription diabetes medication 🇸🇬 Singapore Rybelsus 14 mg semaglutide 14 mg tablets Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription diabetes medicine

Rybelsus 7 mg Tablet contains semaglutide, a GLP-1 receptor agonist used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Semaglutide helps regulate blood glucose by increasing insulin release when blood sugar is elevated, reducing glucagon secretion, and slowing gastric emptying. Rybelsus may also help reduce appetite and food intake. UK Rybelsus 7 mg semaglutide 7 mg tablets Rybelsus tablets semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects oral semaglutide prescription diabetes medicine 🇺🇸 USA Rybelsus 7 mg semaglutide 7 mg Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription semaglutide 🇮🇳 India Rybelsus 7 mg semaglutide 7 mg tablets Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects diabetes treatment tablets 🇨🇦 Canada Rybelsus 7 mg semaglutide 7 mg Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription diabetes medication 🇰🇷 South Korea Rybelsus 7 mg semaglutide 7 mg Rybelsus tablets oral semaglutide semaglutide diabetes treatment Rybelsus uses Rybelsus side effects prescription semaglutide 🇸🇬 Singapore Rybelsus 7 mg semaglutide 7 mg tablets Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription diabetes medicine 🇦🇺 Australia Rybelsus 7 mg semaglutide 7 mg Rybelsus tablets oral semaglutide semaglutide for type 2 diabetes Rybelsus uses Rybelsus side effects prescription semaglutide

Rybelsus 3 mg Tablet contains semaglutide, a GLP-1 receptor agonist used along with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. The 3 mg strength is typically used as the starting dose to help the body adjust before the dose is increased as prescribed by a healthcare professional. UK: Rybelsus 3mg, Rybelsus 3mg tablets UK, semaglutide 3mg UK, Rybelsus tablets UK, Rybelsus semaglutide UK, type 2 diabetes medicine UK USA: Rybelsus 3mg, Rybelsus 3mg tablets USA, semaglutide 3mg USA, Rybelsus tablets USA, Rybelsus semaglutide USA Australia: Rybelsus 3mg Australia, Rybelsus tablets Australia, semaglutide 3mg Australia, Rybelsus semaglutide Australia India: Rybelsus 3mg India, Rybelsus tablets India, semaglutide 3mg India, Rybelsus semaglutide India South Korea: Rybelsus 3mg South Korea, Rybelsus tablets Korea, semaglutide 3mg Korea, Rybelsus semaglutide Korea Canada: Rybelsus 3mg Canada, Rybelsus tablets Canada, semaglutide 3mg Canada, Rybelsus semaglutide Canada Singapore: Rybelsus 3mg Singapore, Rybelsus tablets Singapore, semaglutide 3mg Singapore, Rybelsus semaglutide Singapore

Brand / Product: Gluformin XL 1000 mg Dosage form: Extended‑Release (XL) Tablet Strength: 1000 mg (1 g) per tablet Composition : Active Ingredient: Metformin Hydrochloride 1000 mg (extended‑release) Therapeutic Classification : Therapeutic class: Antidiabetic agent Pharmacological class: Biguanide glucose‑lowering agent Formulation & Release : Extended‑Release (XL): Designed to release metformin slowly over time for: Improved tolerability Once‑daily dosing convenience Reduced gastrointestinal side effects compared with immediate‑release forms Route & Administration : Route: Oral (by mouth) Administration: Usually taken once daily with food (as prescribed) to maximize absorption and reduce stomach upset Mechanism of Action : Reduces hepatic glucose production (liver) Improves insulin sensitivity in muscle and fat cells Decreases intestinal glucose absorption This leads to lower blood glucose levels in patients with type 2 diabetes. Gluformin XL 1000 Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control blood sugar levels and thus prevents serious complications of diabetes. It is also used to treat a menstruation-related disorder known as polycystic ovary syndrome (PCOS) in women. Gluformin XL 1000 mg contains Metformin Hydrochloride (Extended-Release), an oral antidiabetic medicine. Main Uses : Type 2 Diabetes Mellitus Helps control high blood sugar levels in adults and adolescents. Can be used alone or with other antidiabetic medicines (e.g., sulfonylureas, DPP‑4 inhibitors, insulin). Often prescribed as first-line therapy for type 2 diabetes. Prediabetes / Prevention May be used in high-risk individuals to prevent or delay the onset of type 2 diabetes. Polycystic Ovary Syndrome (PCOS) Improves insulin resistance. Helps regulate menstrual cycles and promotes ovulation in some patients. Weight Management in Diabetic Patients Helps manage blood sugar without causing weight gain. May lead to mild weight reduction in overweight patients. How It Works : Reduces glucose production in the liver. Improves insulin sensitivity in muscle and fat cells. Decreases absorption of glucose from the gut. Extended-release (XL) formulation allows once-daily dosing and reduces gastrointestinal side effects.

Medicine Name: Sitasmart-M 50/500 mg Tablet Form: Oral tablet Strength: Sitagliptin 50 mg + Metformin 500 mg per tablet Category: Antidiabetic (Type 2 diabetes control) Composition : Sitagliptin 50 mg – a DPP-4 inhibitor that helps increase insulin release after meals. Metformin 500 mg – a biguanide that reduces liver glucose production, delays intestinal glucose absorption, and improves insulin sensitivity. Therapeutic Class : Antidiabetic combination medicine – used to control high blood sugar levels in Type 2 diabetes mellitus. Key Properties : Route: Oral (swallowed whole with water) Administration: Usually taken with or after food to reduce stomach upset. Dosage: typically once or twice daily based on sugar levels and response. Storage: Store in a cool, dry place away from direct sunlight. Sitasmart-M is an oral antidiabetic medicine used to control Type 2 Diabetes Mellitus. 🩸 Main Use : Type 2 Diabetes – Helps lower and control high blood sugar levels. Key Uses and Benefits : Type 2 Diabetes Management: Controls blood sugar levels in adults. Improved Insulin Sensitivity: Helps the body use existing insulin more effectively. Decreased Liver Glucose Production: Lowers the amount of sugar produced by the liver. Prevents Complications: Helps prevent long-term diabetes complications like kidney damage, blindness, and heart disease. SITASMART M 50/500 MG tablet is a combination medication containing Sitagliptin (50 mg) and Metformin (500 mg) used to treat Type 2 diabetes mellitus in adults. It helps control high blood sugar levels—particularly after meals—by enhancing insulin sensitivity, reducing liver glucose production, and increasing insulin release. It should be used with diet and exercise. How it helps : It contains two medicines that work together: Metformin (500 mg) Decreases glucose production in the liver Improves insulin sensitivity Reduces sugar absorption from the intestine Sitagliptin (50 mg) Increases insulin release after meals Reduces excess glucagon (a hormone that raises blood sugar) Together, they help : Maintain stable blood sugar levels Reduce risk of diabetes-related complications (kidney damage, nerve damage, eye problems, heart disease)

Generic Name: Sitagliptin 100 mg Tablet Brand Name: Sitasmart 100 Tablet Composition : Each tablet contains: Sitagliptin 100 mg — active ingredient Pharmaceutical Details Dosage Form: Film-coated tablet Strength: 100 mg Packaging: Commonly available in strips of 10 tablets per pack Route of Administration: Oral Storage: Store in a cool, dry place below ~25–30 °C and protect from moisture & light Therapeutic Class Antidiabetic medicine — DPP-4 inhibitor (dipeptidyl peptidase-4 inhibitor) Sitasmart 100 mg tablet is a prescription medication used to treat Type 2 diabetes mellitus, typically in combination with diet and exercise. As a DPP-4 inhibitor (Sitagliptin), it works by increasing insulin production after meals and decreasing excess glucose production by the liver. It helps control blood sugar levels to reduce diabetes-related complications. Primary Uses and Benefits Type 2 Diabetes Management: Improves glycemic control in adults. Insulin Regulation: Increases insulin release from the pancreas. Glucose Control: Reduces the amount of sugar produced by the liver. HbA1c Reduction: Helps lower long-term blood sugar markers. Mechanism of Action Sitagliptin inhibits the DPP-4 enzyme, increasing incretin hormones. This leads to increased insulin secretion (when blood glucose is high) and decreased glucagon release, ultimately helping lower blood sugar levels. Indications (Uses) Management of Type 2 diabetes mellitus in adults. Used together with diet and exercise when blood glucose levels are not controlled adequately by lifestyle measures alone. Primary Use Type 2 Diabetes Mellitus Helps control high blood sugar levels in adults when used along with diet and exercise. How it helps Increases insulin release when blood sugar is high Reduces excess glucose production by the liver Helps maintain stable blood sugar throughout the day Combination Therapy Can be used alone or with other antidiabetic medicines such as: Metformin Sulfonylureas

Brand name: METGEM Strength: 1 gram Active ingredient: Ceftriaxone 1 g (confirm on vial) Dosage form: Injection (powder for reconstitution) Route of administration: Intravenous (IV) or Intramuscular (IM) Therapeutic Class Antibiotic Third-generation cephalosporin Indications (Uses) Respiratory tract infections Urinary tract infections Typhoid fever Bloodstream infections (septicemia) Skin & soft tissue infections Bone & joint infections Abdominal infections Meningitis Gonorrhea Surgical infection prophylaxis Mechanism of Action Inhibits bacterial cell wall synthesis, leading to bacterial death. Dosage Adults: usually 1–2 g once or twice daily Children: dose based on body weight